Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis

• Main Authors: Akio Tanaka (Author), Ken Igawa (Author), Hidetoshi Takahashi (Author), Ryosuke Shimizu (Author), Yoko Kataoka (Author), Hitoe Torisu-Itakura (Author), Yoji Morisaki (Author), Sonia Montmayeur (Author), Norito Katoh (Author)
• Format: Book
• Published: Medical Journals Sweden, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Lebrikizumab has previously demonstrated efficacy in Phase 3 trials: ADvocate1 and ADvocate2 (as monotherapy), ADhere, and ADhere-J (in combination with topical corticosteroids). Here, the impact of lebrikizumab combined with low- to mid-potency topical corticosteroids on patient-reported outcomes a...